Ali Zarrabi
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 0.2%
Papers in
-
- Advanced biosensing and bioanalysis techniques 35
- RNA Interference and Gene Delivery 32
- Circular RNAs in diseases 29
-
- Graphene and Nanomaterials Applications 64
- Nanoplatforms for cancer theranostics 39
- Co-authors
- Milad Ashrafizadeh (104 shared papers)Kiavash Hushmandi (77 shared papers)Atefeh Zarepour (101 shared papers)Amirhossein Zabolian (50 shared papers)Pooyan Makvandi (45 shared papers)Sepideh Mirzaei (45 shared papers)Gautam Sethi (19 shared papers)Masoud Najafi (30 shared papers)
In The Last Decade
Ali Zarrabi
352 papers receiving 14.9k citations
Ali Zarrabi's Hit Papers
Peers
Comparison fields: 5 of 178
- Biomaterials 3.1k
- Molecular Medicine 1.1k
- Cancer Research 2.8k
- Pharmaceutical Science 817
- Molecular Biology 6.2k
Countries citing papers authored by Ali Zarrabi
This map shows the geographic impact of Ali Zarrabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Zarrabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Zarrabi more than expected).
Fields of papers citing papers by Ali Zarrabi
This network shows the impact of papers produced by Ali Zarrabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Zarrabi. The network helps show where Ali Zarrabi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Zarrabi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 369 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties Hit paper breakdown → | 2018 | 434 |
| 2 | Emerging role of exosomes in cancer progression and tumor microenvironment remodeling Hit paper breakdown → | 2022 | 393 |
| 3 | 2017 | 222 | |
| 4 | 2020 | 202 | |
| 5 | 2020 | 199 | |
| 6 | 2021 | 195 | |
| 7 | 2020 | 187 | |
| 8 | 2021 | 186 | |
| 9 | Lycopene: Food Sources, Biological Activities, and Human Health Benefits Hit paper breakdown → | 2021 | 180 |
| 10 | 2017 | 172 | |
| 11 | Customizing nano-chitosan for sustainable drug delivery Hit paper breakdown → | 2022 | 170 |
| 12 | 2019 | 167 | |
| 13 | NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition Hit paper breakdown → | 2022 | 161 |
| 14 | 2021 | 155 | |
| 15 | 2020 | 154 | |
| 16 | 2021 | 153 | |
| 17 | 2021 | 150 | |
| 18 | 2022 | 145 | |
| 19 | 2021 | 142 | |
| 20 | 2021 | 138 |
About Ali Zarrabi
Ali Zarrabi is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Materials Chemistry and Cancer Research, having authored 369 papers that have together received 15.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (66 papers), Graphene and Nanomaterials Applications (64 papers), Cancer-related molecular mechanisms research (46 papers), Nanoplatforms for cancer theranostics (39 papers), Advanced biosensing and bioanalysis techniques (35 papers), MicroRNA in disease regulation (35 papers), RNA Interference and Gene Delivery (32 papers) and Circular RNAs in diseases (29 papers). The work is most often cited by research in Biomaterials (3.1k citations), Molecular Medicine (1.1k citations), Cancer Research (2.8k citations), Pharmaceutical Science (817 citations) and Molecular Biology (6.2k citations). Ali Zarrabi has collaborated with scholars based in Iran, Türkiye and India. Frequent co-authors include Milad Ashrafizadeh, Kiavash Hushmandi, Atefeh Zarepour, Amirhossein Zabolian, Pooyan Makvandi, Sepideh Mirzaei, Gautam Sethi, Masoud Najafi, Reza Mohammadinejad and Farid Hashemi. Their work appears in journals such as International Journal of Biological Macromolecules, Life Sciences, Pharmaceutics, RSC Advances and Journal of Drug Delivery Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.